ENXTPA:ML
ENXTPA:MLAuto Components

Revisiting Michelin (ENXTPA:ML) Valuation After Recent Share Price Reversal

Should You Take Another Look at Compagnie Générale des Établissements Michelin Société en commandite par actions (ENXTPA:ML)? Sometimes, a stock creeps onto your radar simply because its recent moves feel out of step with the broader market. That is where Compagnie Générale des Établissements Michelin Société en commandite par actions (ENXTPA:ML) sits today. Nothing has triggered urgent headlines this week, but investors might notice the share price eking out a small gain this month after...
ENXTPA:EXA
ENXTPA:EXAAerospace & Defense

Exail Technologies (ENXTPA:EXA) Reports 47% Price Increase Over The Last Quarter

Exail Technologies (ENXTPA:EXA) recently achieved a significant milestone with the first sale of its DriX H-9 autonomous surface drone to a global hydrographic authority for naval defense, enhancing its foothold in the USV market. This came alongside a major European navy's order for five DriX H-8 drones. These developments, along with the confirmed expectation of double-digit revenue growth for 2025, likely bolstered market sentiment, aligning with the overall market's strong performance and...
ENXTPA:NRO
ENXTPA:NROIT

Neurones (ENXTPA:NRO) Half-Year Sales Surpass €424M But Net Income Declines

Neurones (ENXTPA:NRO) reported its half-year earnings, showing an increase in sales to EUR 424 million but a decline in net income to EUR 23 million. Despite these mixed results, the company's share price rose 3.8% last week. This movement coincides with broader market trends, as major stock indexes, including the Dow Jones and S&P 500, experienced record highs amid anticipation of interest rate cuts by the Federal Reserve. While the sales growth from Neurones supports the broader positive...
ENXTPA:VETO
ENXTPA:VETOPharmaceuticals

Vetoquinol (ENXTPA:VETO) Discusses 2025 Half-Year Financials In Recent Board Meeting

Vetoquinol (ENXTPA:VETO) recently convened a board meeting on September 9 to review and approve its financial statements for the first half of 2025. Despite this significant internal event, the company's stock price remained flat over the last week, aligning with the broader market trends. Major U.S. stock indices like the Dow Jones and S&P 500 reached record highs, buoyed by encouraging inflation data and interest rate cut hopes. While the neutral movement of Vetoquinol's share price mirrors...